ArticleJournal of clinical hypertension (Greenwich, Conn.)2017

Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.

Julia Wetzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.